FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Moore

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
David J DiLillo; D R Friedman; Jon P Gockerman; Russell P Hall; M Horikawa; Y Iwata; Mark C Lanasa; Takashi Matsushita; K M Matta; Joseph O Moore; G Russo; Guglielmo M Venturi; A D Volkheimer; J Brice Weinberg; A Yoshizaki; J M Bryant; Youwei Chen; L F Diehl; Thomas F Tedder
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
Jason H Mendler; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jihane Khalife; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Maria R Baer; Heiko Becker; Clara D Bloomfield
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Margaret R O'Donnell; Farhad Ravandi; Paul J Shami; B Douglas Smith; Richard M Stone; Stephen A Strickland; Martin S Tallman; Eunice S Wang; Camille N Abboud; Jessica Altman; Frederick R Appelbaum; Daniel A Arber; Eyal Attar; Uma Borate; Steven E Coutre; Lloyd E Damon; Salil Goorha; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Michael Millenson; Joseph O Moore; Maoko Naganuma; Kristina M Gregory
Acute myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David J DiLillo; D R Friedman; Jon P Gockerman; Russell P Hall; M Horikawa; Y Iwata; Mark C Lanasa; Takashi Matsushita; K M Matta; Joseph O Moore; G Russo; Guglielmo M Venturi; A D Volkheimer; J Brice Weinberg; A Yoshizaki; J M Bryant; Youwei Chen; L F Diehl; Thomas F Tedder
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
Leukemia 2013;27(1):170-82.
2012: Jason H Mendler; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jihane Khalife; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Maria R Baer; Heiko Becker; Clara D Bloomfield
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3109-18.
2012: Margaret R O'Donnell; Farhad Ravandi; Paul J Shami; B Douglas Smith; Richard M Stone; Stephen A Strickland; Martin S Tallman; Eunice S Wang; Camille N Abboud; Jessica Altman; Frederick R Appelbaum; Daniel A Arber; Eyal Attar; Uma Borate; Steven E Coutre; Lloyd E Damon; Salil Goorha; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Michael Millenson; Joseph O Moore; Maoko Naganuma; Kristina M Gregory
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(8):984-1021.
2012: Ann-Kathrin Eisfeld; Jonathan E Kolitz; Richard A Larson; Sandya Liyanarachchi; Kati Maharry; Guido Marcucci; Jason H Mendler; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Ravi Patel; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Stephan M Tanner; Meir Wetzler; Susan P Whitman; Yue-Zhong Wu; Maria R Baer; Heiko Becker; Michael A Caligiuri; Thomas H Carter; ALBERT DE LA CHAPELLE; Clara D Bloomfield
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood 2012;120(2):249-58.
2012: Guido Marcucci; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Yue-Zhong Wu; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Maria R Baer; Heiko Becker; Clara D Bloomfield
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):742-50.
2012: Mark C Lanasa; Zhiguo Li; Karen M B Matta; Joseph O Moore; Catherine W Rehder; J Brice Weinberg; Harry Cook; Michael Datto; F Joseph Daugherty; Patricia H Davis; Carlos M DeCastro; Louis F Diehl; Daphne R Friedman; Jon P Gockerman; David A Rizzieri
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Leukemia & lymphoma 2012;53(2):218-24.
2011: Dale J Christensen; Evan D Davis; Carlos M de Castro; Louis F Diehl; Daphne R Friedman; Jon P Gockerman; Barbara K Goodman; Mark C Lanasa; Karen M Matta; Joseph O Moore; Jessica Erin Neil; Jessica Oddo; Michael P Vitek; Alicia D Volkheimer; Youwei Chen; J Brice Weinberg
SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.
Blood 2011;118(15):4150-8.
2011: Heiko Becker; Maria R Baer; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Yue-Zhong Wu; Clara D Bloomfield
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica 2011;96(10):1488-95.
2011: Maria R Baer; Stephen L George; B L Sanford; Krzysztof Mrózek; Jonathan E Kolitz; Joseph O Moore; Richard M Stone; Bayard L Powell; Michael A Caligiuri; Clara D Bloomfield; Richard A Larson
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720.
Leukemia 2011;25(5):800-7.
2011: Klaus Metzeler; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Heiko Becker; John Curfman; Kelsi B Holland; Sebastian Schwind; Susan P Whitman; Yue-Zhong Wu; William Blum; Bayard L Powell; Thomas H Carter; Meir Wetzler; Joseph O Moore; Jonathan E Kolitz; Maria R Baer; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(10):1373-81.
2011: Margaret R O'Donnell; Camille N Abboud; Jessica Altman; Frederick R Appelbaum; Steven E Coutre; Lloyd E Damon; James M Foran; Salil Goorha; Lori J Maness; Guido Marcucci; Peter Maslak; Michael M Millenson; Joseph O Moore; Farhad Ravandi; Paul J Shami; B Douglas Smith; Richard M Stone; Stephen A Strickland; Martin S Tallman; Eunice S Wang
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(3):280-317.
2010: Sebastian Schwind; Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Kelsi B Holland; Dean Margeson; Heiko Becker; Susan P Whitman; Yue-Zhong Wu; Klaus Metzeler; Bayard L Powell; Jonathan E Kolitz; Thomas H Carter; Joseph O Moore; Maria R Baer; Andrew J Carroll; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010;116(25):5660-9.
2010: Susan P Whitman; Kati Maharry; Michael D Radmacher; Heiko Becker; Krzysztof Mrózek; Dean Margeson; Kelsi B Holland; Yue-Zhong Wu; Sebastian Schwind; Klaus Metzeler; Jing Wen; Maria R Baer; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Joseph O Moore; Richard M Stone; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010;116(18):3622-6.
2010: Y M Mowery; J Brice Weinberg; M N Kennedy; K M Bond; Joseph O Moore; Mark C Lanasa; Jon P Gockerman; L F Diehl; S V Pizzo; George J Cianciolo; D R Friedman
LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells.
Leukemia 2010;24(9):1580-7.
2010: Heiko Becker; Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Susan P Whitman; Peter Paschka; Kelsi B Holland; Sebastian Schwind; Yue-Zhong Wu; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Joseph O Moore; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010;116(5):788-92.
2010: Christopher A Crout; Liang-Piu Koh; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Gwynn D Long; Louis Diehl; Cristina Gasparetto; Donna Niedzwiecki; Jon Edwards; Leonard R Prosnitz; Mitchell Horwitz; Jon Chute; Ashley Morris; Patricia Davis; Anne Beaven; Nelson J Chao; Francis Ali-Osman; David A Rizzieri
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.
Cancer investigation 2010;28(6):654-60.
2010: Mark C Lanasa; S D Allgood; A D Volkheimer; Jon P Gockerman; John F Whitesides; Barbara K Goodman; Joseph O Moore; J Brice Weinberg; Marc C Levesque
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.
Leukemia 2010;24(1):133-40.
2010: Cristina Gasparetto; Jon P Gockerman; Louis F Diehl; Carlos M de Castro; Joseph O Moore; Gwynn D Long; Mitchell E Horwitz; George Keogh; John P Chute; Keith M Sullivan; Rachel Neuwirth; Patricia H Davis; Linda M Sutton; Russell D Anderson; Nelson J Chao; David A Rizzieri
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):70-7.
2009: Daphne R Friedman; J Brice Weinberg; William T Barry; Barbara K Goodman; Alicia D Volkheimer; Karen M Bond; Youwei Chen; Ning Jiang; Joseph O Moore; Jon P Gockerman; Louis F Diehl; Carlos M Decastro; Anil Potti; Joseph R Nevins
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):6947-55.
2009: Susan O'Brien; Ellin Berman; Hossein Borghaei; Daniel J Deangelo; Marcel P Devetten; Steven Devine; Harry P Erba; Jason Gotlib; Madan Jagasia; Joseph O Moore; Tariq Mughal; Javier Pinilla-Ibarz; Jerald P Radich; Neil P Shah Md; Paul J Shami; B Douglas Smith; David S Snyder; Martin S Tallman; Moshe Talpaz; Meir Wetzler
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):984-1023.
2009: David A Rizzieri; Jenny A O'Brien; Gloria Broadwater; Carlos M DeCastro; Prakash Dev; Louis Diehl; Anne Beaven; Anand S Lagoo; Jon P Gockerman; Nelson J Chao; Joseph O Moore
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
Cancer 2009;115(13):2922-9.
2008: Margaret R O'Donnell; Frederick R Appelbaum; Steven E Coutre; Lloyd E Damon; Harry P Erba; James Foran; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Peter Maslak; Michael Millenson; Joseph O Moore; Farhad Ravandi; Friedrich Schuening; Paul Shami; B Douglas Smith; Richard M Stone; Martin S Tallman; Eunice S Wang; Frank L White
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):962-93.
2008: Arati V Rao; Islam R Younis; Gregory J Sand; Ivan Spasojevic; David J Adams; Carlos M DeCastro; Jon P Gockerman; Bercedis L Peterson; William P Petros; Joseph O Moore; David A Rizzieri
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Leukemia & lymphoma 2008;49(8):1523-9.
2008: Marc C Levesque; Dipak K Ghosh; Bethany E Beasley; Youwei Chen; Alicia D Volkheimer; Charles W O'Loughlin; Jon P Gockerman; Joseph O Moore; J Brice Weinberg
CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant.
Leukemia research 2008;32(7):1061-70.
2007: J Brice Weinberg; Alicia D Volkheimer; Youwei Chen; Bethany E Beasley; Ning Jiang; Mark C Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W Rehder; Carlos M DeCastro; David A Rizzieri; Louis F Diehl; Jon P Gockerman; Joseph O Moore; Barbara K Goodman; Marc C Levesque
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
American journal of hematology 2007;82(12):1063-70.
2007: Susan O'Brien; Ellin Berman; Kapil N Bhalla; Edward A Copelan; Marcel P Devetten; Peter D Emanuel; Harry P Erba; Peter L Greenberg; Joseph O Moore; Donna Przepiorka; Jerald P Radich; Russell J Schilder; Paul Shami; B Douglas Smith; David S Snyder; Robert J Soiffer; Martin S Tallman; Moshe Talpaz; Meir Wetzler
Chronic myelogenous leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(5):474-96.
2007: Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.
Blood 2007;109(4):1559-67.
2006: Richard T Hoppe; Ranjana Advani; Philip J Bierman; Clara D Bloomfield; Francis Buadi; Benjamin Djulgegovic; Andres Forero; Leo I Gordon; Francisco J Hernandez-Ilizaliturri; Mark S Kaminski; Gena Love; David G Maloney; Peter M Mauch; Joseph O Moore; Russell J Schilder; Lawrence Weiss; Jane N Winter; Joachim Yahalom; Andrew D Zelenetz
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(3):210-30.
2006: Bridget F Koontz; John P Kirkpatrick; Robert W Clough; Robert G Prosnitz; Jon P Gockerman; Joseph O Moore; Leonard R Prosnitz
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):605-11.
2006: Margaret R O'Donnell; Frederick R Appelbaum; Maria R Baer; John C Byrd; Steven E Coutre; Lloyd E Damon; Harry P Erba; Eli Estey; James Foran; Jeffrey Lancet; Lori J Maness; Peter Maslak; Michael Millenson; Joseph O Moore; Donna Przepiorka; Paul Shami; B Douglas Smith; Richard M Stone; Martin S Tallman
Acute myeloid leukemia clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):16-36.
2006: Marc C Levesque; Youwei Chen; Bethany E Beasley; Charles W O'Loughlin; Jon P Gockerman; Joseph O Moore; J Brice Weinberg
Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.
Leukemia research 2006;30(1):24-8.
2005: Guido Marcucci; Claudia D Baldus; Amy S Ruppert; Michael D Radmacher; Krzysztof Mrózek; Susan P Whitman; Jonathan E Kolitz; Colin G Edwards; James W Vardiman; Bayard L Powell; Maria R Baer; Joseph O Moore; Danilo Perrotti; Michael A Caligiuri; Andrew J Carroll; Richard A Larson; Albert de La Chapelle; Clara D Bloomfield
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9234-42.
2005: Susan O'Brien; Ellin Berman; Kapil N Bhalla; Edward A Copelan; Marcel P Devetten; Peter D Emanuel; Harry P Erba; Peter L Greenberg; Joseph O Moore; Donna Przepiorka; Jerald P Radich; Russell J Schilder; Paul Shami; B Douglas Smith; David S Snyder; Robert J Soiffer; Martin S Tallman; Moshe Talpaz; Meir Wetzler
Chronic myelogenous leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(6):732-55.
2005: Guido Marcucci; Krzysztof Mrózek; Amy S Ruppert; Kati Maharry; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Mark J Pettenati; Bayard L Powell; Colin G Edwards; Lisa J Sterling; James W Vardiman; Charles Alan Schiffer; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5705-17.
2005: Myron S Czuczman; Aron Thall; Thomas E Witzig; Julie M Vose; Anas Younes; Christos Emmanouilides; Thomas P Miller; Joseph O Moore; John P Leonard; Leo I Gordon; John Sweetenham; Baha Alkuzweny; Deborah M Finucane; Bryan R Leigh
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4390-8.
2005: Joseph O Moore; Stephen L George; Richard K Dodge; Philip C Amrein; Bayard L Powell; Jonathan E Kolitz; Maria R Baer; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Charles Alan Schiffer
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
Blood 2005;105(9):3420-7.
2005: Carlos A Tirado; Siby Sebastian; Joseph O Moore; Jerald Z Gong; Barbara K Goodman
Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion.
Cancer genetics and cytogenetics 2005;157(1):74-7.
2005: Sherif S Farag; Amy S Ruppert; Krzysztof Mrózek; Robert J Mayer; Richard M Stone; Andrew J Carroll; Bayard L Powell; Joseph O Moore; Mark J Pettenati; Prasad R K Koduru; Judith Stamberg; Maria R Baer; AnneMarie W Block; James W Vardiman; Jonathan E Kolitz; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):482-93.
2004: Jonathan E Kolitz; Stephen L George; Richard K Dodge; David D Hurd; Bayard L Powell; Steven Allen; Enrique Velez-Garcia; Joseph O Moore; Thomas C Shea; Eva Hoke; Michael A Caligiuri; James W Vardiman; Clara D Bloomfield; Richard A Larson
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4290-301.
2004: Jeffrey Talbot; Valerie K Ibom; David A Rizzieri; Robert Barrier; Donna Niedzwieki; Carlos M DeCastro; Joseph O Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Rumbaugh; Jon P Gockerman
Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.
Clinical lymphoma 2004;5(2):116-22.
2004: David A Rizzieri; Gamal Akabani; Michael R Zalutsky; R Edward Coleman; Scott D Metzler; James Bowsher; Bonnie Toaso; Elizabeth Anderson; Anand S Lagoo; Steve Clayton; Charles N Pegram; Joseph O Moore; Jon P Gockerman; Carlos M DeCastro; Cristina Gasparetto; Nelson J Chao; Darell D Bigner
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.
Blood 2004;104(3):642-8.
2004: David A Rizzieri; Gregory J Sand; Dean McGaughey; Joseph O Moore; Carlos M DeCastro; Nelson J Chao; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Elizabeth Anderson; Traci Foster; Bonnie Toaso; David Adams; Donna Niedzwiecki; Jon P Gockerman
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
Cancer 2004;100(11):2408-14.
2004: Mikkael A Sekeres; Bercedis Peterson; Richard K Dodge; Robert J Mayer; Joseph O Moore; Edward J Lee; Jonathan E Kolitz; Maria R Baer; Charles Alan Schiffer; Andrew J Carroll; James W Vardiman; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Richard M Stone
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood 2004;103(11):4036-42.
2004: John C Byrd; Amy S Ruppert; Krzysztof Mrózek; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Judith Stamberg; Prasad R K Koduru; Joseph O Moore; Robert J Mayer; Frederick R Davey; Richard A Larson; Clara D Bloomfield
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1087-94.
2004: Clara D Bloomfield; Amy S Ruppert; Krzysztof Mrózek; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Colin G Edwards; Lisa J Sterling; James W Vardiman; Andrew J Carroll; Mark J Pettenati; Judith Stamberg; John C Byrd; Guido Marcucci; Richard A Larson
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Annals of hematology 2004;83 Suppl 1():S84-5.
2003: Valerie K Ibom; Robert G Prosnitz; Jerald Z Gong; Joseph O Moore; Carlos M DeCastro; Leonard R Prosnitz; David A Rizzieri; Jon P Gockerman
Rituximab in lymphocyte predominance Hodgkin's disease: a case series.
Clinical lymphoma 2003;4(2):115-8.
2003: Claudia D Baldus; Stephan M Tanner; Amy S Ruppert; Susan P Whitman; Kellie J Archer; Guido Marcucci; Michael A Caligiuri; Andrew J Carroll; James W Vardiman; Bayard L Powell; Steven Allen; Joseph O Moore; Richard A Larson; Jonathan E Kolitz; Albert de La Chapelle; Clara D Bloomfield
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
Blood 2003;102(5):1613-8.
2003: Carlos A Tirado; V Golembiewski-Ruiz; Joseph M Horvatinovich; Joseph O Moore; Patrick J Buckley; Timothy T Stenzel; Barbara K Goodman
Cytogenetic and molecular analysis of an unusual case of acute promyelocytic leukemia with a t(15;17;17)(q22;q23;q21).
Cancer genetics and cytogenetics 2003;145(1):31-7.
2003: Jeffrey Talbot; David A Rizzieri; Carlos M DeCastro; Joseph O Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Brumbaugh; Jon P Gockerman
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series.
American journal of hematology 2003;73(4):295-6.
2003: Jerald Z Gong; Timothy T Stenzel; Ellen R Bennett; Anand S Lagoo; Dunphy Cherie; Joseph O Moore; David A Rizzieri; James Tepperberg; Peter Papenhausen; Patrick J Buckley
Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases.
The American journal of surgical pathology 2003;27(6):818-27.
2003: David A Rizzieri; Valerie K Ibom; Joseph O Moore; Carlos M DeCastro; Gary Rosner; David J Adams; Traci Foster; Nancy Payne; Maria Thompson; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Nelson J Chao; Jon P Gockerman
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):663-8.
2002: John C Byrd; Krzysztof Mrózek; Richard K Dodge; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Shivanand R Patil; Kathleen W Rao; Michael S Watson; Prasad R K Koduru; Joseph O Moore; Richard M Stone; Robert J Mayer; Eric J Feldman; Frederick R Davey; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
Blood 2002;100(13):4325-36.
2002: Sherif S Farag; Kellie J Archer; Krzysztof Mrózek; James W Vardiman; Andrew J Carroll; Mark J Pettenati; Joseph O Moore; Jonathan E Kolitz; Robert J Mayer; Richard M Stone; Richard A Larson; Clara D Bloomfield
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
International journal of oncology 2002;21(5):1041-51.
2002: Adam J Bass; Jon P Gockerman; Eve Hammett; Carlos M DeCastro; David J Adams; Gary Rosner; Nancy Payne; Patti Davis; Traci Foster; Joseph O Moore; David A Rizzieri
Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2995-3000.
2002: Steven L McCune; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Adam J Bass; Nelson J Chao; Gwynn D Long; James J Vredenburgh; Cristina Gasparetto; David Adams; Nancy Payne; David A Rizzieri
Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.
Leukemia & lymphoma 2002;43(5):1007-11.
2002: David A Rizzieri; Adam J Bass; Gary Rosner; Jon P Gockerman; Carlos M DeCastro; William P Petros; David J Adams; Mary J Laughlin; Patti Davis; Traci Foster; Robert Jacobson; Herbert I Hurwitz; Joseph O Moore
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):674-9.
2001: Keith R Berend; R Pietrobon; Joseph O Moore; Louis R Dibernardo; John M Harrelson; Sean P Scully
Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
Journal of surgical oncology 2001;78(3):162-70.
2001: Richard M Stone; D T Berg; Stephen L George; Richard K Dodge; P A Paciucci; Philip Schulman; Edward J Lee; Joseph O Moore; Bayard L Powell; Maria R Baer; Clara D Bloomfield; Charles Alan Schiffer
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
Blood 2001;98(3):548-53.
2001: Maria R Baer; Carleton C Stewart; Richard K Dodge; G Leget; N Sulé; Krzysztof Mrózek; Charles Alan Schiffer; Bayard L Powell; Jonathan E Kolitz; Joseph O Moore; Richard M Stone; Frederick R Davey; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
Blood 2001;97(11):3574-80.
1999: John C Byrd; Richard K Dodge; Andrew J Carroll; Maria R Baer; C Edwards; Judith Stamberg; Mazin B Qumsiyeh; Joseph O Moore; Robert J Mayer; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3767-75.
1999: W C Lin; Joseph O Moore; Karen P Mann; ST Traweek; Clayton Smith
Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection.
Leukemia & lymphoma 1999;33(3-4):377-84.
1998: William T Sumner; James Grichnik; Christopher R Shea; Joseph O Moore; W S Miller; Claude S Burton
Follicular mucinosis as a presenting sign of acute myeloblastic leukemia.
Journal of the American Academy of Dermatology 1998;38(5 Pt 2):803-5.
1998: Mary J Laughlin; David A Rizzieri; C A Smith; Joseph O Moore; S Lilly; Dean McGaughey; P Martin; Carmelita Carrier; Cladd E Stevens; Pablo Rubinstein; R Buckley; Joanne Kurtzberg
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.
Leukemia research 1998;22(3):215-9.
1997: Krzysztof Mrózek; K Heinonen; David S Lawrence; Andrew J Carroll; Prasad R K Koduru; Kathleen W Rao; Matthew P Strout; R E Hutchison; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.
Blood 1997;90(11):4532-8.
1997: Karen P Mann; Carlos M DeCastro; J Liu; Joseph O Moore; Sandra H Bigner; ST Traweek
Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
American journal of clinical pathology 1997;107(6):653-60.
1997: James M Provenzale; P Schaefer; ST Traweek; J Ferry; Joseph O Moore; A H Friedman; Roger E McLendon
Craniocerebral plasmacytoma: MR features.
AJNR. American journal of neuroradiology 1997;18(2):389-92.
1997: John C Byrd; R B Weiss; Diane C Arthur; David S Lawrence; Maria R Baer; Frederick R Davey; E S Trikha; Andrew J Carroll; Ramana Tantravahi; Mazin B Qumsiyeh; Shivanand R Patil; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):466-75.
1997: Joseph O Moore; Richard K Dodge; Philip C Amrein; Jonathan E Kolitz; Edward J Lee; B Powell; S Godfrey; F Robert; Charles Alan Schiffer
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.
Blood 1997;89(3):780-8.
1997: Rex M McCallum; Dhavalkumar D Patel; Joseph O Moore; B F Haynes
Arthritis syndromes associated with human T cell lymphotropic virus type I infection.
The Medical clinics of North America 1997;81(1):261-76.
1995: P J Shami; Joseph O Moore; Jon P Gockerman; J W Hathorn; Mary A Misukonis; J Brice Weinberg
Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells.
Leukemia research 1995;19(8):527-33.
1995: P A Robiolio; V H Rigolin; J Kevin Harrison; James E Lowe; Joseph O Moore; Thomas M Bashore; Jerome M Feldman
Predictors of outcome of tricuspid valve replacement in carcinoid heart disease.
The American journal of cardiology 1995;75(7):485-8.
1994: David M. Brizel; Jon P Gockerman; Jeffrey Crawford; J W Hathorn; Joseph O Moore; B Osborne; Leonard R Prosnitz
A pilot study of etoposide, vinblastine, and doxorubicin plus involved field irradiation in advanced, previously untreated Hodgkin's disease.
Cancer 1994;74(1):159-63.
1994: S Mastovich; Howard Ratech; R E Ware; Joseph O Moore; Michael J Borowitz
Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation.
Human pathology 1994;25(1):102-8.
1993: N C Robben; A W Pippas; Joseph O Moore
The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy.
Cancer 1993;71(2):493-509.
1991: Wendell F Rosse; S Hoffman; M Campbell; Michael J Borowitz; Joseph O Moore; C J Parker
The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
British journal of haematology 1991;79(1):99-107.
1990: David M. Brizel; Eric P Winer; Leonard R Prosnitz; J Scott; Jeffrey Crawford; Joseph O Moore; Jon P Gockerman
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy.
International journal of radiation oncology, biology, physics 1990;19(3):535-42.
1990: DC Longee; Henry S Friedman; R E Albright; Peter C Burger; W Jerry Oakes; Joseph O Moore; S Clifford Schold
Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine.
Journal of neurosurgery 1990;72(4):583-8.
1989: Michael W Hanson; Jerome M Feldman; Russell A Blinder; Joseph O Moore; R Edward Coleman
Carcinoid tumors: iodine-131 MIBG scintigraphy.
Radiology 1989;172(3):699-703.
1989: S Grufferman; Harvey Jay Cohen; Elizabeth Delzell; M C Morrison; S Clifford Schold; Joseph O Moore
Familial aggregation of multiple myeloma and central nervous system diseases.
Journal of the American Geriatrics Society 1989;37(4):303-9.
1989: Michael J Borowitz; Jon P Gockerman; Joseph O Moore; Curt I Civin; SO Page; J Robertson; Sandra H Bigner
Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia.
American journal of clinical pathology 1989;91(3):265-70.
1989: Joanne Kurtzberg; Thomas Waldmann; Michael P Davey; S H Bigner; Joseph O Moore; Michael S Hershfield; Barton F Haynes
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells.
Blood 1989;73(2):381-90.
1989: William P Peters; A Stuart; M Klotman; Colleen Gilbert; R B Jones; E J Shpall; Jon P Gockerman; Robert C Bast; Joseph O Moore
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study.
Cancer chemotherapy and pharmacology 1989;23(6):377-83.
1988: Virginia B Kraus; E A Harden; B Wittels; Joseph O Moore; Barton F Haynes
Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
The American journal of pathology 1988;132(3):552-62.
1988: Richard H Cohan; M E Baker; C Cooper; Joseph O Moore; M Saeed; N Reed Dunnick
Computed tomography of primary retroperitoneal malignancies.
Journal of computer assisted tomography 1988;12(5):804-10.
1988: William P Peters; E J Shpall; R B Jones; G A Olsen; Robert C Bast; Jon P Gockerman; Joseph O Moore
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1368-76.
1988: M J Knapp; Victor L Roggli; J Kim; Joseph O Moore; J D Shelburne
Pleural amyloidosis.
Archives of pathology & laboratory medicine 1988;112(1):57-60.
1987: A A Hertler; Joseph O Moore
Sarcomas in the elderly.
Clinics in geriatric medicine 1987;3(4):781-801.
1984: E A Harden; Joseph O Moore; Barton F Haynes
Leukemia-associated arthritis: identification of leukemic cells in synovial fluid using monoclonal and polyclonal antibodies.
Arthritis and rheumatism 1984;27(11):1306-8.
1984: Joseph O Moore; G A Olsen
Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
Seminars in oncology 1984;11(3 Suppl 1):41-6.